Portfolio company
NeurOdys Therapeutics
Netherlands
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
3 investors
Sectors
About
This biotechnology company develops small molecule therapies for neurodegenerative disorders including Alzheimer's and Parkinson's diseases for healthcare providers and patients.
SourceFunding history · 1
Similar companies
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
Tetraneuron
This company develops gene therapies to treat Alzheimer's and other neurodegenerative diseases for healthcare providers and patients.
Bioarctic Biociences
This biopharmaceutical company develops antibody-based disease-modifying treatments for neurodegenerative disorders, such as Alzheimer's and Parkinson's, for healthcare providers and patients.
Mitokinin
This biotechnology company develops small molecule drugs to treat Parkinson's disease and other neurodegenerative conditions for patients and healthcare providers.
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
